F9 embryonal carcinoma cells engineered for tamoxifen-dependent Cre-mediated site-directed mutagenesis and doxycycline-inducible gene expression.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Experimental Cell Research

• Publication date

  2000-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/EXCR.2000.5022PMID 11035928
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Inducible site‐specific somatic mutagenesis in mouse hepatocytes

  2000cited by this paper
• Engineering the mouse genome by site-specific recombination.

  1999cited by this paper
• Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases.

  1999cited by this paper
• Mammalian TAFII30 is required for cell cycle progression and specific cellular differentiation programmes

  1999cited by this paper
• Mouse P450RAI (CYP26) Expression and Retinoic Acid-inducible Retinoic Acid Metabolism in F9 Cells Are Regulated by Retinoic Acid Receptor γ and Retinoid X Receptor α*

  1998cited by this paper
• Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains.

  1997cited by this paper
• Gene targeting: things go better with Cre.

  1997cited by this paper
• Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells

  1997cited by this paper
• SNF2beta-BRG1 is essential for the viability of F9 murine embryonal carcinoma cells

  1997cited by this paper
• Specific and Redundant Functions of Retinoid X Receptor/Retinoic Acid Receptor Heterodimers in Differentiation, Proliferation, and Apoptosis of F9 Embryonal Carcinoma Cells

  1997cited by this paper
• Spatio-temporally controlled site-specific somatic mutagenesis in the mouse.

  1997cited by this paper
• Recent advances in gene mutagenesis by site-directed recombination.

  1996cited by this paper
• Ligand-activated site-specific recombination in mice.

  1996cited by this paper
• A decade of molecular biology of retinoic acid receptors

  1996cited by this paper
• RXRalpha‐null F9 embryonal carcinoma cells are resistant to the differentiation, anti‐proliferative and apoptotic effects of retinoids.

  1996cited by this paper
• Diverse strategies for tetracycline-regulated inducible gene expression.

  1996cited by this paper
• Conditional gene targeting.

  1996cited by this paper
• Recent advances in gene mutagenesis by site-directed recombination.

  1996cited by this paper
• Transcriptional activation by tetracyclines in mammalian cells.

  1995cited by this paper
• Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase.

  1995cited by this paper
• Use of tetracycline operator system to regulate oncogene expression in mammalian cells.

  1995cited by this paper
• Tightly regulated and inducible expression of dominant interfering dynamin mutant in stably transformed HeLa cells.

  1995cited by this paper
• The Retinoids : biology, chemistry, and medicine

  1994cited by this paper
• Site-specific recombination: developments and applications.

  1994cited by this paper
• Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system.

  1994cited by this paper
• TKO'ed: lox, stock and barrel.

  1994cited by this paper
• Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements.

  1994cited by this paper
• Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements

  1993cited by this paper
• Loss of retinoic acid receptor gamma function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment.

  1993cited by this paper
• Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

  1992cited by this paper
• Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells

  1990cited by this paper
• Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1.

  1988cited by this paper
• Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter.

  1987cited by this paper
• Use of a recombinant retrovirus to study post‐implantation cell lineage in mouse embryos.

  1986cited by this paper
• Mouse teratocarcinoma cells: prospects for the study of embryogenesis and neoplasia.

  1981cited by this paper

• A Novel Tight Junction–Nuclear Receptor Signaling Pathway Regulating Cancer Progression

  2025cites this paper
• The Src-Family Kinases SRC and BLK Contribute to the CLDN6-Adhesion Signaling

  2023cites this paper
• A novel signaling pathway linking cell-cell adhesion to nuclear receptors

  2023cites this paper
• A “Hit and Run” Approach to Inducible Direct Reprogramming of Astrocytes to Neural Stem Cells

  2016influential citation
• A Sox10rtTA/+ Mouse Line Allows for Inducible Gene Expression in the Auditory and Balance Organs of the Inner Ear

  2015cites this paper
• The Tight-Junction Protein Claudin-6 Induces Epithelial Differentiation from Mouse F9 and Embryonic Stem Cells

  2013cites this paper
• Development of a Chromosomally Integrated Metabolite-Inducible Leu3p-α-IPM “Off-On” Gene Switch

  2010cites this paper
• The nuclear receptor hepatocyte nuclear factor 4α acts as a morphogen to induce the formation of microvilli

  2006cites this paper
• Molecular Cardiology

  2005cites this paper
• Strategies of conditional gene expression in myocardium: an overview.

  2005cites this paper
• Inducible transgene expression in mouse stem cells.

  2005cites this paper
• Activation of p21CIP1/WAF1 gene expression and inhibition of cell proliferation by overexpression of hepatocyte nuclear factor-4alpha.

  2005cites this paper
• Behavior of tight-junction, adherens-junction and cell polarity proteins during HNF-4alpha-induced epithelial polarization.

  2005cites this paper
• Strategies of Conditional Gene Expression in Myocardium

  2005cites this paper
• Thr(207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP.

  2004cites this paper
• Hepatocyte nuclear factor (HNF)-4alpha triggers formation of functional tight junctions and establishment of polarized epithelial morphology in F9 embryonal carcinoma cells.

  2003cites this paper
• Thr203 of claudin-1, a putative phosphorylation site for MAP kinase, is required to promote the barrier function of tight junctions.

  2003cites this paper
• Conditional gene activation in cultured hepatocytes using a ligand-dependent chimeric Cre recombinase.

  2003cites this paper
• Hepatocyte nuclear factor (HNF)-4α triggers formation of functional tight junctions and establishment of polarized epithelial morphology in F9 embryonal carcinoma cells

  2003cites this paper
• Effets vasculaires des œstrogènes

  2003cites this paper
• [Usefulness of experimental models to understand the vascular effects of estrogens].

  2003cites this paper
• Induction of cre recombinase activity using modified androgen receptor ligand binding domains: a sensitive assay for ligand-receptor interactions.

  2003cites this paper
• Gene regulation by tetracyclines.

  2003cites this paper
• Jcb: Article Introduction

  2002cites this paper
• Tetracycline-dependent gene regulation: combinations of transregulators yield a variety of expression windows.

  2002cites this paper
• The devil is in the level : the role of the transcription factor GATA-1 in erythropoiesis

  2002cites this paper
• Retinoid X Receptor α and Retinoic Acid Receptor γ Mediate Expression of Genes Encoding Tight-Junction Proteins and Barrier Function in F9 Cells during Visceral Endodermal Differentiation

  2001cites this paper
• Retinoid X receptor alpha and retinoic acid receptor gamma mediate expression of genes encoding tight-junction proteins and barrier function in F9 cells during visceral endodermal differentiation.

  2001cites this paper